These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 6105547)
1. Toxicity of gliadin in coeliac patients. Patey AL Lancet; 1980 Aug; 2(8191):427-8. PubMed ID: 6105547 [No Abstract] [Full Text] [Related]
2. Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease. Ciclitira PJ; Ellis HJ; Fagg NL Br Med J (Clin Res Ed); 1984 Jul; 289(6437):83. PubMed ID: 6428688 [No Abstract] [Full Text] [Related]
3. Clinical testing of bread made from nullisomic 6A wheats in coeliac patients. Ciclitira PJ; Hunter JO; Lennox ES Lancet; 1980 Aug; 2(8188):234-6. PubMed ID: 6105397 [TBL] [Abstract][Full Text] [Related]
4. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins. Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076 [TBL] [Abstract][Full Text] [Related]
6. The relation between gliadin structure and its toxicity to glutensensitive patients. Hekkens WT Minerva Pediatr; 1977 Nov; 29(37):2191-6. PubMed ID: 600226 [No Abstract] [Full Text] [Related]
7. Stimulation of lymphocytes from patients with coeliac disease by subfraction of gluten. Lancet; 1976 Sep; 2(7986):629-30. PubMed ID: 61364 [No Abstract] [Full Text] [Related]
8. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis. Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727 [TBL] [Abstract][Full Text] [Related]
9. [Decrease of the cytotoxicity of gliadin fractions in the development of celiac disease. Organotypic culture study]. Arnaud-Battandier F; Magazzu G; Schmitz J; Jos J; Rey J Arch Fr Pediatr; 1985 Mar; 42(3):245-8. PubMed ID: 4004485 [TBL] [Abstract][Full Text] [Related]
10. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients. Pizzuti D; Buda A; D'Odorico A; D'IncĂ R; Chiarelli S; Curioni A; Martines D Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124 [TBL] [Abstract][Full Text] [Related]
15. Non-specific cytotoxicity of wheat gliadin components towards cultured human cells. Hudson DA; Cornell HJ; Purdham DR; Rolles CJ Lancet; 1976 Feb; 1(7955):339-41. PubMed ID: 54743 [TBL] [Abstract][Full Text] [Related]
16. Lysosomal damage by gliadin and gliadin peptides; an activity not related to coeliac disease. de Rooij FW; van den Aarsen CP; Hekkens WT Clin Chim Acta; 1979 Jan; 91(2):127-31. PubMed ID: 759040 [TBL] [Abstract][Full Text] [Related]
17. [In vitro intestinal cytotoxicity of various fractions from gliadin or cows's milk proteins in children: quantitative assessment by a morphometric method]. Olives JP; Schmitz J; Jos J; de Tand MF; Rey J Gastroenterol Clin Biol; 1982; 6(6-7):557-62. PubMed ID: 7117767 [No Abstract] [Full Text] [Related]
18. Cytotoxic effects of wheat gliadin-derived peptides. Paganuzzi AS; Zucco F; Cardelli M; de Angelis I; Mattei R; Pino A; Rocca E; Zampaglioni F Toxicology; 1985 Dec; 37(3-4):225-32. PubMed ID: 4071551 [TBL] [Abstract][Full Text] [Related]
19. An in vitro model for gluten enteropathy. Nutr Rev; 1980 Apr; 38(4):161-3. PubMed ID: 7207883 [No Abstract] [Full Text] [Related]